Annexon Ownership | Who Owns Annexon?

Annexon Ownership Summary

Annexon is owned by 80.16% institutional investors, 0.50% insiders, and 19.34% retail investors. Fmr is the largest institutional shareholder, holding 10.17% of ANNX shares. BB Biotech AG Ord is the top mutual fund, with 4.84% of its assets in Annexon shares.

ANNX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Annexon	80.16%	0.50%	19.34%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	14.22M	10.17%	$72.97M
Blackrock funding, inc. /de	8.49M	6.06%	$43.53M
Blackrock	6.59M	5.37%	$32.28M
Alerce investment management	7.41M	5.29%	$37.99M
Bvf inc/il	7.00M	5.00%	$35.91M
Redmile group	6.30M	4.50%	$32.32M
Point72 asset management	5.63M	4.02%	$28.87M
Vanguard group	5.55M	3.96%	$28.46M
Bain capital life sciences investors	5.25M	3.75%	$26.93M
Bellevue group	5.16M	3.69%	$26.46M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Alerce investment management	7.41M	66.89%	$37.99M
Sio capital management	2.37M	3.42%	$12.14M
Bain capital life sciences investors	5.25M	3.17%	$26.93M
Redmile group	6.30M	2.25%	$32.32M
Tfg asset management gp	1.40M	1.77%	$7.18M
Logos global management lp	2.55M	1.53%	$13.08M
Bvf inc/il	7.00M	1.22%	$35.91M
Sphera funds management	1.24M	1.15%	$6.38M
Exome asset management	144.83K	0.56%	$742.98K
Bellevue group	5.16M	0.51%	$26.46M

Top Buyers

Holder	Shares	% Assets	Change
Fmr	14.22M	0.00%	5.66M
Blackrock	6.59M	0.00%	1.54M
Sphera funds management	1.24M	1.15%	1.24M
Eventide asset management	1.02M	0.10%	1.02M
Sio capital management	2.37M	3.42%	933.85K

Top Sellers

Holder	Shares	% Assets	Change
Bain capital life sciences investors	5.25M	3.17%	-3.20M
Adage capital partners gp	-	-	-2.84M
Gmt capital	-	-	-1.91M
Pictet asset management sa	-	-	-1.64M
Polar capital	-	-	-1.00M

New Positions

Holder	Shares	% Assets	Change	Value
Sphera funds management	1.24M	1.15%	1.24M	$6.38M
Eventide asset management	1.02M	0.10%	1.02M	$5.22M
Ghost tree capital	214.50K	0.33%	214.50K	$1.05M
J. safra sarasin	155.74K	0.01%	155.74K	$798.97K
Exome asset management	144.83K	0.56%	144.83K	$742.98K

Sold Out

Holder	Change
National bank of canada /fi/	-2.00
Nelson, van denburg & campbell wealth management group	-9.00
Quadrant capital group	-34.00
Lindbrook capital	-83.00
Parallel advisors	-122.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	155	6.16%	112,163,548	1.74%	80	1.29%	88	10.00%	38	2.70%
Sep 30, 2024	146	-7.01%	110,248,434	2.42%	78	1.02%	80	-18.37%	37	15.63%
Jun 30, 2024	157	16.30%	107,640,091	13.59%	87	1.47%	98	22.50%	32	14.29%
Mar 31, 2024	135	32.35%	94,758,161	17.52%	77	0.73%	80	42.86%	28	3.70%
Dec 31, 2023	102	5.15%	80,631,348	50.51%	103	2.04%	56	30.23%	27	-6.90%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
BB Biotech AG Ord	5.16M	4.84%	-
Fidelity Growth Compy Commingled Pl S	4.14M	3.77%	5.60K
Vanguard Total Stock Mkt Idx Inv	3.01M	2.74%	-
Fidelity Growth Company Fund	2.98M	2.72%	-
Vanguard US Total Market Shares ETF	2.83M	2.58%	-
iShares Russell 2000 ETF	2.59M	2.36%	-22.50K
Candriam Eqs L Biotech C USD Cap	2.53M	2.31%	-
Fidelity Growth Compy Commingled Pl O	2.37M	2.25%	-
SPDR® S&P Biotech ETF	2.32M	2.11%	-14.13K
CT (Lux) American Smaller Com 9U USD	1.85M	1.68%	24.05K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Feb 18, 2025	Dananberg Jamie	CHIEF MEDICAL OFFICER	Sell	$16.34K
Feb 18, 2025	ARTIS DEAN RICHARD	EVP & CHIEF SCIENTIFIC OFFICER	Sell	$16.38K
Feb 18, 2025	Yednock Ted	EVP & CHIEF INNOVATION OFFICER	Sell	$24.28K
Feb 18, 2025	Overdorf Michael	EVP & CHIEF BUSINESS OFFICER	Sell	$19.52K
Feb 18, 2025	Lew Jennifer	EVP & CHIEF FINANCIAL OFFICER	Sell	$20.18K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	9
2024 Q4	2	1
2024 Q3	3	7
2024 Q2	3	-
2024 Q1	-	7

ANNX Ownership FAQ

Who Owns Annexon?

Annexon shareholders are primarily institutional investors at 80.16%, followed by 0.50% insiders and 19.34% retail investors. The average institutional ownership in Annexon's industry, Biotech Stocks , is 68.48%, which Annexon exceeds.

Who owns the most shares of Annexon?

Annexon’s largest shareholders are Fmr (14.22M shares, 10.17%), Blackrock funding, inc. /de (8.49M shares, 6.06%), and Blackrock (6.59M shares, 5.37%). Together, they hold 21.60% of Annexon’s total shares outstanding.

Does Blackrock own Annexon?

Yes, BlackRock owns 5.37% of Annexon, totaling 6.59M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 32.28M$. In the last quarter, BlackRock increased its holdings by 1.54M shares, a 30.61% change.

Who is Annexon’s biggest shareholder by percentage of total assets invested?

Alerce investment management is Annexon’s biggest shareholder by percentage of total assets invested, with 66.89% of its assets in 7.41M Annexon shares, valued at 37.99M$.

Who is the top mutual fund holder of Annexon shares?

BB Biotech AG Ord is the top mutual fund holder of Annexon shares, with 4.84% of its total shares outstanding invested in 5.16M Annexon shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools